Metraipolis › archive › dc_5a0fff9febef

Interleukin-17 in disease pathogenesis and therapy: recent advances in targeted drug design and medicinal chemistry — Europe PMC PMID:42568824

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42568824
DOI
10.3389/fphar.2026.1836187
License (as archived)
solo-consultazione
Archived
2026-10-18T06:48:08.261Z
SHA-256 of the archived text
0fb71c366b345f8ea348ce4f61d9178051811902a79926abf0879f444fe28d51
Stable URL of this page
https://metraipolis.com/documento/dc_5a0fff9febef

How to cite

Interleukin-17 in disease pathogenesis and therapy: recent advances in targeted drug design and medicinal chemistry — Europe PMC PMID:42568824 — Europe PMC (en), https://europepmc.org/article/MED/42568824 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5a0fff9febef (Metraipolis archive dc_5a0fff9febef, sha256 0fb71c366b345f8ea348ce4f61d9178051811902a79926abf0879f444fe28d51)
BibTeX
@misc{dc5a0fff9febef,
  title = {Interleukin-17 in disease pathogenesis and therapy: recent advances in targeted drug design and medicinal chemistry — Europe PMC PMID:42568824},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42568824},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5a0fff9febef; sha256 0fb71c366b345f8ea348ce4f61d9178051811902a79926abf0879f444fe28d51},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42568824. Agents can read the archived copy with the MCP tool read_document.